Bailard, Inc. Assertio Holdings, Inc. Transaction History

Bailard, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$2.52 - $5.69 $13,104 - $29,588	-5,200 Reduced 10.36%	44,985 $115,000
Q2 2023 Jul 20, 2023	SELL	$5.0 - $7.66 $38,000 - $58,216	-7,600 Reduced 13.15%	50,185 $272,000
Q1 2023 May 08, 2023	SELL	$3.54 - $6.66 $63,012 - $118,548	-17,800 Reduced 23.55%	57,785 $368,000
Q4 2022 Feb 02, 2023	BUY	$2.11 - $4.3 $85,001 - $173,225	40,285 Added 114.12%	75,585 $325,000
Q3 2022 Oct 18, 2022	BUY	$2.13 - $4.0 $7,668 - $14,400	3,600 Added 11.36%	35,300 $80,000
Q2 2022 Jul 27, 2022	BUY	$1.88 - $3.42 $59,596 - $108,414	31,700 New	31,700 $94,000

114

37.2M

755K

39.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $58.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.